精彩内容日前，2025年A股收官，回顾全年市场走势强劲。医药板块方面，截至2025年12月31日收盘，9只医药股市值超千亿元规模，百济神州狂飙1900亿元“登顶”，恒瑞医药、药明康德等均有双位数涨幅，云南白药冲击中药股“一哥”宝座，海思科、常山药业、信立泰等跻身TOP20之列；从涨跌幅来看，近7成医药股市值上涨，32只翻倍，多瑞医药、常山药业等涨幅超过200%，舒泰神、苑东生物等晋身百亿梯队。...
Source Link精彩内容日前，2025年A股收官，回顾全年市场走势强劲。医药板块方面，截至2025年12月31日收盘，9只医药股市值超千亿元规模，百济神州狂飙1900亿元“登顶”，恒瑞医药、药明康德等均有双位数涨幅，云南白药冲击中药股“一哥”宝座，海思科、常山药业、信立泰等跻身TOP20之列；从涨跌幅来看，近7成医药股市值上涨，32只翻倍，多瑞医药、常山药业等涨幅超过200%，舒泰神、苑东生物等晋身百亿梯队。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.